Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Consumers worry about hospital mergers

It’s no secret the healthcare industry is undergoing massive consolidation, and hospital mergers and acquisitions are a concern among more than 60 percent of American adults, according to a new survey.

Thumbnail

55% of hospitals earn payment bump through value-based purchasing

Just 55 percent of hospitals will earn a payment increase under the Medicare value-based purchasing program in 2019, according to CMS.

Thumbnail

AMA: Nine institutions made major improvements in physician burnout

Physician burnout is a widespread problem across the healthcare industry, but nine organizations stand out in their commitment and progress to prevent and alleviate the issue, according to the American Medical Association (AMA).

Thumbnail

Hospital groups launch suit against HHS

Hospital groups have launched a lawsuit against HHS over its new outpatient prospective payment system rule, which was finalized in November.

Thumbnail

Humana to buy back $750M in stocks

Health insurance and services provider Humana has announced it will accelerate stock repurchase of $750 million.

Thumbnail

CVS launches new PBM pricing model

As CVS Health continues to deal with the closure of its $69 billion acquisition of Aetna, its pharmacy benefit manager (PBM) branch is moving ahead with a new pricing model. The new focus could help guarantee net cost predictability and simplify pricing.

Thumbnail

CVS-Aetna deal faces hurdle as WellCare buys out Part D biz

CVS Health has closed its $69 billion acquisition of health insurer Aetna after the deal was approved by all necessary regulators, but the transaction has hit a snag after a judge requested more information from the Department of Justice.

Thumbnail

Trump administration details state of healthcare competition

In the midst of a major consolidation period in the healthcare industry, a new report from the Trump administration sheds light on the current state of competition in the space.

Displaying 3001 - 3008 of 6655

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup